Rudolph Hulspas
Dana-Farber Cancer Institute
Ruud Hulspas is Technical Director of Process Development at Dana-Farber Cancer Institute. He is a Key Opinion Leader in cytometry with executive leadership experience and expertise in standards, quality, and controls in cell-based analytics. He is highly motivated to move commercial cell therapy forward through effective coordination between academic research, process development, CMC, and regulatory agencies. Ruud is a team leader capable of influencing through scientifically sound yet practical decisions. He earned his Ph.D. in Biology from the University of Amsterdam.
Seminars
Wednesday 16th September 2026
Optimizing Starting Materials to Enable Future Scalable Cell Therapy Production
11:15 am
- Providing strategies to effectively isolate key starting materials to enhance product yield
- Assessing cell phenotype and fitness to understand how starting material quality impacts manufacturing success
- Applying engineering and process innovations to improve low quality autologous starting material and enable reliable production for clinical supply
